Cited by 459Autophagy in Disease and TherapyChronic Obstructive Pulmonary Disease (COPD) ResearchCalcium signaling and nucleotide metabolism

Egr-1 Regulates Autophagy in Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease

Open access
Chen, Zhi-Hua, Kim, Hong Pyo, Sciurba, Frank C., Lee, Seon-Jin, Feghali-Bostwick, Carol, Stolz, Donna B., Dhir, Rajiv, Landreneau, Rodney J. +8 more·2008·PLoS ONE

Abstract

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a progressive lung disease characterized by abnormal cellular responses to cigarette smoke, resulting in tissue destruction and airflow limitation. Autophagy is a degradative process involving lysosomal turnover of cellular components, though its role in human diseases remains unclear. METHODOLOGY AND PRINCIPAL FINDINGS: Increased autophagy was observed in lung tissue from COPD patients, as indicated by electron microscopic analysis, as well as by increased activation of autophagic proteins (microtubule-associated protein-1 light chain-3B, LC3B, Atg4, Atg5/12, Atg7). Cigarette smoke extract (CSE) is an established model for studying the effects of cigarette smoke exposure in vitro. In human pulmonary epithelial cells, exposure to CSE or histone deacetylase (HDAC) inhibitor rapidly induced autophagy. CSE decreased HDAC activity, resulting in increased binding of early growth response-1 (Egr-1) and E2F factors to the autophagy gene LC3B promoter, and increased LC3B expression. Knockdown of E2F-4 or Egr-1 inhibited CSE-induced LC3B expression. Knockdown of Egr-1 also inhibited the expression of Atg4B, a critical factor for LC3B conversion. Inhibition of autophagy by LC3B-knockdown protected epithelial cells from CSE-induced apoptosis. Egr-1(-/-) mice, which displayed basal airspace enlargement, resisted cigarette-smoke induced autophagy, apoptosis, and emphysema. CONCLUSIONS: We demonstrate a critical role for Egr-1 in promoting autophagy and apoptosis in response to cigarette smoke exposure in vitro and in vivo. The induction of autophagy at early stages of COPD progression suggests novel therapeutic targets for the treatment of cigarette smoke induced lung injury.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0003316

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Several reports pointed out enhanced autophagy in COPD muscle, confirming data observed in the lung.

    “After that, several reports pointed out an enhanced autophagy in COPD muscle, confirming the data observed in the lung [180].”

    From Main Pathogenic Mechanisms and Recent Advances in COPD Peripheral Skeletal Muscle Wasting (2023) · cites this paper as [180]

    The Results section, “Increased autophagy in human COPD lung tissues” (page unavailable), reports increased autophagy markers and autophagic vacuoles in COPD lung tissue. It does not report enhanced autophagy in COPD muscle or substantiate the claim that several reports found it there. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Autophagy is increased in the lungs of COPD patients.

    “It is already established that autophagy is increased in the lungs of COPD patients [180].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 42

  1. [1]Celli BR MacNee W ATS/ERS Task Force 2004 Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 23 932 946 15219010
  2. [2]Barnes PJ 2000 Chronic obstructive pulmonary disease. N Engl J Med 343 269 280 10911010
  3. [3]Mayer AS Newman LS 2001 Genetic and environmental modulation of chronic obstructive pulmonary disease. Respir Physiol 128 3 11 11535256
  4. [4]Barnes PJ Shapiro SD Pauwels RA 2003 Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 22 672 688 14582923
  5. [5]Wang IM Stepaniants S Boie Y Mortimer JR Kennedy B 2007 Gene expression profiling in patients with chronic obstructive pulmonary disease and lung cancer. Am J Respir Crit Care Med 177 402 411 17975202
  6. [6]Ning W Li CJ Kaminski N Feghali-Bostwick CA Alber SM 2004 Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease. Proc Natl Acad Sci USA 101 14895 14900 15469929 PMC522001
  7. [7]Lee SL Sadovsky Y Swirnoff AH Polish JA Goda P 1996 Luteinizing hormone deficiency and female infertility in mice lacking the transcription factor NGFI-A (Egr-1). Science 273 1219 1221 8703054
  8. [8]Yan SF Pinsky DJ Mackman N Stern DM 2000 Egr-1: is it always immediate and early? J Clin Invest 105 553 554 10712422 PMC292461
  9. [9]Ito K Ito M Elliott WM Cosio B Caramori G 2005 Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med 352 1967 1976 15888697
  10. [10]Narlikar GJ Fan HY Kingston RE 2002 Cooperation between complexes that regulate chromatin structure and transcription. Cell 108 475 487 11909519
  11. [11]Henson PM Vandivier RW Douglas IS 2006 Cell death, remodeling, and repair in chronic obstructive pulmonary disease? Proc Am Thorac Soc 3 713 717 17065379 PMC2647658
  12. [12]Yokohori N Aoshiba K Nagai A 2004 Increased levels of cell death and proliferation in alveolar wall cells in patients with pulmonary emphysema. Chest 125 626 632 14769747
  13. [13]Kasahara Y Tuder RM Cool CD 2001 Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am J Respir Crit Care Med 163 737 744 11254533
  14. [14]Petrache I Natarajan V Zhen L Medler TR Richter AT 2005 Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice. Nat Med 11 491 498 15852018 PMC1352344
  15. [15]Kasahara Y Tuder RM Taraseviciene-Stewart L Le Cras TD Abman S 2000 Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest 106 1311 1319 11104784 PMC387249
  16. [16]Levine B Yuan J 2005 Autophagy in cell death: an innocent convict? J Clin Invest 115 2679 2688 16200202 PMC1236698
  17. [17]Levine B Klionsky DJ 2004 Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell 6 463 477 15068787
  18. [18]Yu L Alva A Su H Dutt P Freundt S 2004 Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science 304 1500 1502 15131264
  19. [19]Shimizu S Kanaseki T Mizushima N Mizuta T Arakawa-Kobayashi S 2004 Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat Cell Biol 6 1221 1228 15558033
  20. [20]Yan L Vatner DE Kim SJ Ge H Masurekar M 2005 Autophagy in chronically ischemic myocardium. Proc Natl Acad Sci USA 102 13807 13812 16174725 PMC1224362
  21. [22]Djavaheri-Mergny M Amelotti M Mathieu J Besançon F Bauvy C 2006 NF-kappaB activation represses tumor necrosis factor-alpha-induced autophagy. J Biol Chem 281 30373 30382 16857678
  22. [23]Pattingre S Tassa A Qu X Garuti R Liang XH 2005 Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 122 927 939 16179260
  23. [24]Boya P González-Polo RA Casares N Perfettini JL Dessen P 2005 Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol 25 1025 1040 15657430 PMC543994
  24. [25]Kondo Y Kanzawa T Sawaya R Kondo S 2005 The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 5 726 734 16148885
  25. [27]Klionsky D 2008 Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 4 151 175 18188003 PMC2654259
  26. [28]Yang SR Chida AS Bauter MR Shafiq N Seweryniak K 2006 Cigarette smoke induces proinflammatory cytokine release by activation of NF-kappaB and posttranslational modifications of histone deacetylase in macrophages. Am J Physiol Lung Cell Mol Physiol 291 L46 L57 16473865
  27. [29]Cosio BG Tsaprouni L Ito K Jazrawi E Adcock IM 2004 Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages. J Exp Med 200 689 695 15337792 PMC2212744
  28. [30]Shao Y Gao Z Marks PA Jiang X 2004 Apoptotic and autophagic cell death induced by histone deacetylase inhibitors. Proc Natl Acad Sci USA 101 18030 18035 15596714 PMC539807
  29. [31]Ferreira R Magnaghi-Jaulin L Robin P Harel-Bellan A Trouche D 1998 The three members of the pocket proteins family share the ability to repress E2F activity through recruitment of a histone deacetylase. Proc Natl Acad Sci USA 95 10493 10498 9724731 PMC27922
  30. [32]Iavarone A Massague J 1999 E2F and histone deacetylase mediate transforming growth factor beta repression of cdc25A during keratinocyte cell cycle arrest. Mol Cell Biol 19 916 922 9858615 PMC83949
  31. [33]Lu Z Luo RZ Peng H Huang M Nishmoto A 2006 E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer. Oncogene 25 230 239 16158053
  32. [34]Dunhill M 1962 Quantitative methods in the study of pulmonary pathology. Thorax 17 320 328 25269161 PMC1018718
  33. [35]Shapiro SD 2004 Smoke gets in your cells. Am J Respir Cell Mol Biol 31 481 482 15494469
  34. [36]Adcock IA Tsaprouni L Bhavsar P Ito K 2007 Epigenetic regulation of airway inflammation. Curr Opinion Immunol 19 694 700 17720468
  35. [37]Yorimitsu T Klionsky DJ 2005 Autophagy: molecular machinery for self-eating. Cell Death Differ 12 Suppl 2 1542 1552 16247502 PMC1828868
  36. [38]Landesberg LJ Ramalingam R Lee K Rosengart TK Crystal RG 2001 Upregulation of transcription factors in lung in the early phase of postpneumonectomy lung growth. Am J Physiol Lung Cell Mol Physiol 281 L1138 L1149 11597905
  37. [39]Kuma A Hatano M Matsui M Yamamoto A Nakaya H 2004 The role of autophagy during the early neonatal starvation period. Nature 432 1032 1036 15525940
  38. [41]Cann GM Guignabert C Ying L Deshpande N Bekker JM 2008 Developmental expression of LC3alpha and beta: absence of fibronectin or autophagy phenotype in LC3beta knockout mice. Dev Dyn 237 187 195 18069693
  39. [43]Rioux JD Xavier RJ Taylor KD Silverberg MS Goyette P 2007 Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 39 596 604 17435756 PMC2757939
  40. [44]Hampe J Franke A Rosenstiel P Till A Teuber M 2007 A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 39 207 211 17200669
  41. [45]Global Initiative for Chronic Obstructive Lung Disease (GOLD) Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: NHLBI/WHO workshop report Bethesda, MD National Heart, Lung, and Blood Institute, 2001. (NIH publication no. 2701 11316667
  42. [46]Myerburg MM Latoche JD McKenna EE Stabile LP Siegfried JS 2007 Hepatocyte growth factor and other fibroblast secretions modulate the phenotype of human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol 292 L1352 L1360 17307814

Cited by

Sorted by citations

Authors
Chen, Z.-H., Kim, H. P., Sciurba, F. C., Lee, S.-J., Feghali-Bostwick, C., Stolz, D. B., Dhir, R., Landreneau, R. J., Schuchert, M. J., Yousem, S. A., Nakahira, K., Pilewski, J. M., Lee, J. S., Zhang, Y., Ryter, S. W., & Choi, A. M. K.
Affiliations
  • Brigham and Women's Hospital (US)
  • University of Pittsburgh (US)
Corresponding author
Choi, Augustine M. K.
Venue
PLoS ONE
Published
2008-10-02
Volume
3
Issue
10
Pages
e3316
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2154846778
Cited by
459
References
4
Citations by year
2026: 4 · 2025: 18 · 2024: 15 · 2023: 22 · 2022: 21 · 2021: 27 · 2020: 30 · 2019: 29 · 2018: 35 · 2017: 44 · 2016: 37 · 2015: 35 · 2014: 25 · 2013: 33 · 2012: 27
FWCI
13.90
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • D-Scholarship@Pitt (University of Pittsburgh) (acceptedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • American Heart Association (HL60234)
  • National Institutes of Health (UL1TR000005, R01-HL55330)
  • National Heart, Lung, and Blood Institute (R01HL055330, P01-HL70807, R01HL55330, R01HL079904, R01HL60234, R01HL060234, P01HL070807, P50HL084948)
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Calcium signaling and nucleotide metabolism
Keywords
EGR1, autophagy, chronic obstructive pulmonary disease, cigarette smoke, LC3B, histone deacetylase, E2F4, apoptosis, emphysema, lung epithelial cells, ATG4B, transcriptional regulation, lung injury
MeSH terms
Animals, Autophagy, Humans, Mice, Inbred C57BL, Smoking, Nicotiana, Apoptosis, Pulmonary Disease, Chronic Obstructive, Mice, Early Growth Response Protein 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review